WebJunction Course Catalog
Storytimes
Viruses have become the pathogen of major epidemics. Identifying the potential targets of viruses is particularly important for success. Antibodies and antibody fragments occupy an important therapeutic means against infectious diseases. Because of their high affinity, they can be designed and engineered for a variety of purposes to develop therapeutic and diagnostic reagents. We have many years of research experience in the field of antibody discovery, and is committed to providing antivirus antibody discovery and screening services for customers around the world using its antibody discovery platform based on mRNA display.
Introduction to Antiviral Antibodies
The outbreak and prevalence of viral infectious diseases pose a serious threat to social and economic activities and human life and health, and they are accelerating. Discovering and developing efficient therapies is an urgent requirement to prevent viral outbreaks and epidemics. Monoclonal antibodies (mAbs) have played an undisputed role in eradicating infections due to their unique targeting specificity. mAbs neutralize the virus by blocking the interaction between the virus and the host cell by binding to free virus or to the required receptors on the cell surface to attach the virus and enter the cell. They also help eliminate viral infections by presenting antigens presented on infected target cells (through opsonization of infected cells) to immune system effector cells.
More information: mRNA display-based antiviral antibody screening services
